ValueAct Capital's Jeffrey Ubben Sees a Lot of Upside in Microsoft

Author's Avatar
Apr 30, 2014

ValueAct Capital's Jeffrey Ubben weighs in on some of his favorite companies.

He thinks that the Bill Ackman-led Valeant-Allergan tie up is a great match.

Ubben also sees a lot of future upside for shareholders of behemoth Microsoft (MSFT, Financial).

Â